|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/192 | (2006.01) |
| A61P 1/16 | (2006.01) |
| (11) | Number of the document | 3463328 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17722943.2 |
| Date of filing the European patent application | 2017-04-26 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-15 |
| (46) | Date of publication of the claims translation | 2022-08-10 |
| (86) | Number | PCT/US2017/029620 |
| Date | 2017-04-26 |
| (87) | Number | WO 2017/209865 |
| Date | 2017-12-07 |
| (30) | Number | Date | Country code |
| 201662343688 P | 2016-05-31 | US |
| (72) |
BOUDES, Pol , US
MCWHERTER, Charles, A. , US
|
| (73) |
CymaBay Therapeutics, Inc. ,
7575 Gateway Boulevard, Suite 110, Newark, CA 94560,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Seladelparas pirminiam tulžies cholangitui gydyti |
| SELADELPAR FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS |
| Payment date | Validity (years) | Amount | |
| 2025-03-21 | 9 | 208.00 EUR |
| 2026-04-26 |